Zeng Hua-Ping, Chen Hong, Chen Dan, Ma Guo-Ping, Zhu Xian-Mu, Hong Li-Ting, Liu Xiu-Mian, Ke Yin-Fei
Institute of Senile Disease,Fujian Provincial Hospital Cadre Special Clinic Fuzhou 350001,China Department of Pharmacy,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China.
Institute of Senile Disease,Fujian Provincial Hospital Cadre Special Clinic Fuzhou 350001,China.
Zhongguo Zhong Yao Za Zhi. 2019 May;44(9):1911-1920. doi: 10.19540/j.cnki.cjcmm.20190107.001.
To study the binding capacity of active ingredients of Daidai lipid-lowering flavonoid extract and plasma protein,investigate the ways to improve the traditional formula for calculating protein binding rates based on ultrafiltration,and increase the stability and reliability of the experimental results. UPLC-MS/MS was used to establish a quantitative analysis method for simultaneous determination of active ingredients( neohesperidin and narngin) in ultrafiltrate. The protein binding rates were calculated by the traditional ultrafiltration formula. The correction factors( F) were introduced later,and the binding rates calculated with the correction factors were compared with those without the correction factors. The binding capacity of the extract and plasma protein was evaluated. The quantitative analysis method established by UPLC-MS/MS had a good specificity. The standard curve and linear range,method accuracy,precision and lower limit of quantitation all met the requirements. The method met the requirement for quantitative detection of the active ingredients in ultrafiltrate after the rat plasma was filtrated in the ultrafiltration tube. Under the experimental conditions,the binding rates of both active ingredients( neohesperidin and narngin) were higher than 90%. The active ingredients and rat plasma protein were bound in a concentration-dependent manner,with statistically significant differences( P<0. 01). There was no statistically significant difference between the protein binding abilities of the two active ingredients with rat plasma protein. Therefore,the active ingredients of Daidai lipid-lowering flavonoid extract had a relatively strong binding strength with rat plasma protein,and they were bound in a concentration-dependent manner. Additionally,when calculating protein binding rates by the traditional ultrafiltration formula,the correction factors could be introduced to effectively reflect the errors of multiple ingredient groups in traditional Chinese medicine extracts.This correction method could provide a reference thinking and practical reference for the improvement of the determination method of the traditional Chinese medicine plasma protein binding ability based on ultrafiltration.
为研究代代降脂黄酮提取物活性成分与血浆蛋白的结合能力,探讨改进基于超滤法计算蛋白结合率的传统公式的方法,提高实验结果的稳定性和可靠性。采用超高效液相色谱-串联质谱法(UPLC-MS/MS)建立同时测定超滤液中活性成分(新橙皮苷和柚皮苷)的定量分析方法。采用传统超滤公式计算蛋白结合率,随后引入校正因子(F),比较引入校正因子与未引入校正因子时计算的结合率,评价提取物与血浆蛋白的结合能力。UPLC-MS/MS建立的定量分析方法特异性良好,标准曲线及线性范围、方法准确度、精密度和定量下限均符合要求,该方法满足大鼠血浆经超滤管过滤后超滤液中活性成分定量检测的要求。在实验条件下,两种活性成分(新橙皮苷和柚皮苷)的结合率均高于90%,活性成分与大鼠血浆蛋白呈浓度依赖性结合,差异有统计学意义(P<0.01),两种活性成分与大鼠血浆蛋白的蛋白结合能力差异无统计学意义。因此,代代降脂黄酮提取物活性成分与大鼠血浆蛋白结合强度相对较强,且呈浓度依赖性结合。此外,在采用传统超滤公式计算蛋白结合率时,引入校正因子可有效反映中药提取物多成分组的误差,该校正方法可为基于超滤法的中药血浆蛋白结合能力测定方法改进提供参考思路和实践参考。